Open AccessClinical implications of the universal definition for the prevention and treatment of heart failure
Author(s) -
Chandramouli Chanchal,
Stewart Simon,
Almahmeed Wael,
Lam Carolyn Su Ping
Publication year - 2022
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23842
Subject(s) - medicine , key (lock) , psychological intervention , intensive care medicine , clinical trial , heart failure , health care , engineering ethics , risk analysis (engineering) , nursing , pathology , cardiology , computer science , computer security , economics , engineering , economic growth
The diagnosis of heart failure (HF) primarily relies on signs and symptoms that are neither sensitive nor specific. This impedes timely diagnosis and delays effective therapies or interventions, despite the availability of several evidence‐based treatments for HF. Through monumental collaborative efforts from representatives of HF societies worldwide, the universal definition of HF was published in 2021, to provide the necessary standardized framework required for clinical management, clinical trials, and research. This review elaborates the key concepts of the new universal definition of HF, highlighting the key merits and potential avenues, which can be nuanced further in future iterations. We also discuss the key implications of the universal definition document from the perspectives of various stakeholders within the healthcare framework, including patients, care providers, system/payers and policymakers.